SMS Pharmaceuticals shareholders and shareholding pattern
NSE: SMSPHARMABSE: 532815Pharmaceuticals & BiotechnologySmall Cap
Last close ₹414.60down ₹14.05 (3.28%)BSE ₹414.70
Share price at the NSE close on 23 Oct 2026. Previous close ₹428.65.
52-week range of traded prices to 23 Oct 2026
₹270.10Low, 24 Nov 2025₹494.45High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,883 Cr920th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 31 Jul 2026
- 37.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 4.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.10%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- 14.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.46
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,58,39343.4% delivered
Who owns SMS Pharmaceuticals, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters68.07%
- Foreign institutions1.18%
- Indian institutions0.20%
- Individuals and others30.56%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 18 Jan | Mar 2017Filed 13 Apr | Jun 2017Filed 18 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 11 Jan | Mar 2018Filed 14 Apr | Jun 2018Filed 19 Jul | Sep 2018Filed 5 Oct | Dec 2018Filed 23 Jan | Mar 2019Filed 5 Apr | Jun 2019Filed 11 Jul | Sep 2019Filed 11 Oct | Dec 2019Filed 7 Jan | Mar 2020Filed 15 May | Jun 2020Filed 13 Jul | Sep 2020Filed 30 Oct | Dec 2020Filed 30 Jan | Mar 2021Filed 4 May | Jun 2021Filed 8 Jul | Sep 2021Filed 8 Oct | Dec 2021Filed 7 Jan | Mar 2022Filed 16 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 18 Oct | Dec 2022Filed 11 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 11 Jul | Sep 2023Filed 14 Oct | Dec 2023Filed 11 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 16 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 16 Apr | Jun 2026Filed 10 Jul | Sep 2026Filed 8 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.60% | 67.60% | 67.99% | 67.99% | 67.27% | 67.27% | 67.27% | 67.27% | 67.27% | 67.27% | 67.27% | 67.30% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 64.17% | 64.17% | 64.17% | 64.29% | 64.32% | 64.32% | 64.32% | 64.67% | 64.67% | 64.67% | 64.67% | 66.26% | 66.26% | 68.07% | 68.07% | 68.07% | 68.07% | 68.07% | |
| Indian promoters | 67.60% | 67.60% | 67.99% | 67.99% | 67.27% | 67.27% | 67.27% | 67.27% | 67.27% | 67.27% | 67.27% | 67.30% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 67.29% | 64.17% | 64.17% | 64.17% | 64.29% | 64.32% | 64.32% | 64.32% | 64.67% | 64.67% | 64.67% | 64.67% | 66.26% | 66.26% | 68.07% | 68.07% | 68.07% | 68.07% | 68.07% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 32.40% | 32.40% | 32.01% | 32.01% | 32.73% | 32.73% | 32.73% | 32.73% | 32.73% | 32.73% | 32.73% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 32.71% | 35.83% | 35.83% | 35.83% | 35.71% | 35.68% | 35.68% | 35.68% | 35.33% | 35.33% | 35.33% | 35.33% | 33.74% | 33.74% | 31.93% | 31.93% | 31.93% | 31.93% | 31.93% |
| Promoter shares pledgedShare of the promoters' own shares | 3.55% | 3.55% | 11.00% | 11.00% | 11.12% | 11.12% | 11.12% | 11.12% | 11.12% | 8.90% | 11.12% | 11.11% | 8.83% | 8.83% | 8.83% | 8.83% | 10.24% | 10.24% | 10.24% | 10.24% | 10.24% | 10.24% | 10.73% | 10.73% | 10.73% | 10.71% | 10.71% | 10.71% | 19.51% | 19.40% | 19.40% | 19.40% | 19.40% | 37.60% | 32.49% | 34.65% | 17.99% | 17.99% | 17.99% | 17.99% |
| Shares in issue | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,46,52,030 | 8,86,52,030 | 8,86,52,030 | 9,36,52,030 | 9,36,52,030 | 9,36,52,030 | 9,36,52,030 | 9,36,52,030 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | – | – | – | – | – | – | – | – | – | – | 0 | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,85,15,850 | 3,85,15,850 | 3,85,15,850 | 0 | 0 | 40,00,000 | 90,00,000 | 90,00,000 | 90,00,000 | 90,00,000 | 90,00,000 |
| Promoters' shares locked in | – | – | – | – | – | – | – | – | – | – | – | 0 | – | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,85,15,850 | 3,85,15,850 | 3,85,15,850 | 0 | 0 | 40,00,000 | 90,00,000 | 90,00,000 | 90,00,000 | 90,00,000 | 90,00,000 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
SMS Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is RAMESH BABU POTLURI, 19.38%.Promoter buying and selling
| Holder | ||||
|---|---|---|---|---|
| RAMESH BABU POTLURIIndividuals and Hindu undivided familiesHindu undivided family. A family the tax law treats as one holder: property held in the family's name, shared by its members and managed by one of them. | 19.38% | 1,81,53,060 | 0.00% | 13.77% |
| VAMSI KRISHNA POTLURIIndividuals and Hindu undivided families | 16.90% | 1,58,28,370 | 0.00% | 15.79% |
| HIMA BINDU POTLURIIndividuals and Hindu undivided families | 16.03% | 1,50,08,840 | 19.99% | 0.00% |
| POTLURI INFRA PROJECTS LLPIndian companies, trusts and others | 9.45% | 88,46,420 | 83.04% | 16.96% |
| TRILOK POTLURIIndividuals and Hindu undivided families | 5.01% | 46,88,000 | 0.00% | 53.33% |
| POTLURI LABORATORIES PRIVATE LIMITEDIndian companies, trusts and others | 1.20% | 11,20,320 | 100.00% | 0.00% |
| TVT INFRACON LLPIndian companies, trusts and others | 0.11% | 1,00,000 | 0.00% | 0.00% |
Pledged is the share of the holder's own shares pledged to a lender. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of SMS Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 18 Jan | Mar 2017Filed 13 Apr | Jun 2017Filed 18 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 11 Jan | Mar 2018Filed 14 Apr | Jun 2018Filed 19 Jul | Sep 2018Filed 5 Oct | Dec 2018Filed 23 Jan | Mar 2019Filed 5 Apr | Jun 2019Filed 11 Jul | Sep 2019Filed 11 Oct | Dec 2019Filed 7 Jan | Mar 2020Filed 15 May | Jun 2020Filed 13 Jul | Sep 2020Filed 30 Oct | Dec 2020Filed 30 Jan | Mar 2021Filed 4 May | Jun 2021Filed 8 Jul | Sep 2021Filed 8 Oct | Dec 2021Filed 7 Jan | Mar 2022Filed 16 Apr | Jun 2022Filed 15 Jul | Sep 2022Filed 18 Oct | Dec 2022Filed 11 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 11 Jul | Sep 2023Filed 14 Oct | Dec 2023Filed 11 Jan | Mar 2024Filed 16 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 16 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 17 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 16 Apr | Jun 2026Filed 10 Jul | Sep 2026Filed 8 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIRUDDH MUNDRANon-resident Indians | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | 1.36% | – | 1.36% | 1.36% | 1.36% | 1.16% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.08% | – | 1.02% | 1.03% | – | 2.01% | 1.84% |
| Venkata Subbaraju Penmatsa HUFResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | 1.64% | – | – | 2.13% | 2.13% | 2.13% | – | 2.13% | – | 2.13% | 2.13% | – | – | – | – | – | – | – | – | – | 2.13% | 2.03% | 2.03% | 1.92% | 1.92% | 1.82% | 1.82% | 1.60% |
| ALPANA MUNDRAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.50% |
| SUDEEPTHI GOPINEEDIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.59% | 1.59% | 1.59% | 1.59% | 1.59% | 1.59% | 1.56% | 1.56% | 1.56% | 1.56% | 1.56% | 1.49% | 1.49% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% |
| VENKATA PRAVEEN TALLURIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.53% | 1.53% | 1.53% | 1.53% | 1.53% | 1.53% | 1.56% | 1.56% | 1.56% | 1.56% | 1.56% | 1.49% | 1.49% | 1.41% | 1.41% | 1.41% | 1.41% | 1.41% |
| VIVEK MUNDRANon-resident Indians | 1.37% | 1.37% | 1.37% | 1.37% | 1.37% | 1.37% | – | 1.37% | 1.37% | 1.37% | 1.37% | – | 1.37% | 1.37% | 1.37% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.18% | – | 1.11% | 1.11% | 1.71% | – | – |
| VENKATA SUBBARAJU PENMATSA .Resident individuals, over ₹2 lakh at face value | 2.12% | 2.11% | 2.11% | 2.11% | 2.11% | 2.11% | – | 2.11% | – | – | 2.11% | 3.47% | – | 2.11% | 2.11% | – | – | – | 2.13% | – | 2.13% | – | – | 2.13% | 2.13% | 2.13% | 2.13% | 2.13% | 2.13% | 2.13% | 2.13% | 2.13% | – | – | – | – | – | – | – | – |
| MADHUSUDAN MURLIDHAR KELA ..Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | 1.64% | – | – | – | – | 1.64% | 3.01% | 2.11% | 1.64% | 1.64% | 1.10% | 1.10% | 1.10% | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MADHUSUDAN KELAResident individuals, over ₹2 lakh at face value | – | – | – | – | 1.64% | – | – | 1.05% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MADHUSUDHAN KELAResident individuals, over ₹2 lakh at face value | – | – | – | 1.64% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GULF PHARMACEUTICALS INDUSTRIESOther non-institutions | 1.17% | 1.17% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.